HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,170 | -66.6% | 3,429 | -68.3% | 0.04% | -64.9% |
| Q2 2023 | $920,023 | +239.6% | 10,806 | +230.1% | 0.11% | +226.5% |
| Q1 2023 | $270,924 | +14.6% | 3,274 | +8.9% | 0.03% | +13.3% |
| Q4 2022 | $236,501 | +14.3% | 3,007 | +7.6% | 0.03% | +3.4% |
| Q3 2022 | $207,000 | -1.4% | 2,795 | -13.1% | 0.03% | +3.6% |
| Q2 2022 | $210,000 | -11.4% | 3,218 | -14.2% | 0.03% | +3.7% |
| Q1 2022 | $237,000 | -1.7% | 3,751 | -17.5% | 0.03% | -3.6% |
| Q4 2021 | $241,000 | +1.3% | 4,544 | +35.0% | 0.03% | -6.7% |
| Q3 2021 | $238,000 | +317.5% | 3,366 | +242.1% | 0.03% | -37.5% |
| Q4 2017 | $57,000 | – | 984 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |